IP Infusion reported record-breaking growth in 1Q 2023 with sales at the highest ever level for a single quarter.
The company, which is a wholly owned and independently operated subsidiary of ACCESS CO, said first quarter OcNOS sales orders are more than three times Year over Year compared to Q1 2022, led by robust demand for OcNOS’s disaggregated Data Center, Aggregation Router and Cell Site Router products.
In addition, 23 new customers in the first quarter chose OcNOS, the industry’s first and preferred full-featured modular extensible network OS designed for white box open networking solutions.
“IP Infusion is proud to report yet another unequaled quarter of sales growth fueled by a powerful demand for our industry-acclaimed OcNOS products,” said Atsushi Ogata, President and CEO of IP Infusion. “This solid performance reflects our commitment to exceed expectations for delivering the most advanced disaggregated solutions to our expanding customer base and partners across the globe.”
